Scarica l'app Stockscreener
10.28
0.49%
0.05
Pre-mercato:
10.04
-0.24
-2.33%
Precedente Chiudi:
$10.23
Aprire:
$10.24
Volume 24 ore:
14.46M
Relative Volume:
1.28
Capitalizzazione di mercato:
$47.13B
Reddito:
$14.35B
Utile/perdita netta:
$1.85B
Rapporto P/E:
25.55
EPS:
0.4023
Flusso di cassa netto:
-
1 W Prestazione:
-1.63%
1M Prestazione:
+0.39%
6M Prestazione:
+3.84%
1 anno Prestazione:
+21.37%
Intervallo 1D:
$10.18
$10.30
Intervallo di 1 settimana:
$10.14
$10.34
Portata 52W:
$8.12
$10.80
Haleon Plc Adr Stock (HLN) Company Profile
Confronta HLN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HLN
Haleon Plc Adr
|
10.28 | 47.13B | 14.35B | 1.85B | 0 | 0.4023 |
|
ZTS
Zoetis Inc
|
155.43 | 66.90B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.28 | 48.25B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.58 | 16.06B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
300.76 | 13.15B | 2.76B | 1.11B | 898.10M | 22.77 |
Haleon Plc Adr Stock (HLN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-05 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-01-10 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-08 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2024-08-06 | Iniziato | Berenberg | Buy |
| 2024-08-06 | Downgrade | Goldman | Buy → Neutral |
| 2024-06-05 | Iniziato | Berenberg | Buy |
| 2024-04-17 | Iniziato | HSBC Securities | Buy |
| 2023-12-11 | Ripresa | Jefferies | Buy |
| 2023-11-01 | Iniziato | Morgan Stanley | Overweight |
| 2023-05-24 | Iniziato | Stifel | Hold |
| 2023-04-06 | Aggiornamento | Argus | Hold → Buy |
| 2023-04-04 | Iniziato | Bernstein | Outperform |
| 2022-12-07 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2022-09-28 | Iniziato | Argus | Hold |
Mostra tutto
Haleon Plc Adr Borsa (HLN) Ultime notizie
Haleon adds Matt Shattock to its Board as Non-Executive Director - Investing.com India
Haleon PLC Executes Share Buyback to Optimize Capital Structure - TipRanks
Haleon PLC Executes Share Buyback Program to Enhance Shareholder Value - TipRanks
For iQIYI Inc ADR [IQ], Analyst sees a rise to $2.15. What next? - dbtnews.com
Stocks of Haleon plc ADR (HLN) are poised to climb above their peers - Sete News
Haleon PLC Executes Share Buyback as Part of Strategic Capital Management - TipRanks
Taking a Closer Look At Haleon plc ADR (HLN) Following Its Recent Trade - knoxdaily.com
Haleon plc ADR (HLN) Stock: A 52-Week Tale of Drops and Gains - investchronicle.com
Haleon takes full control of China JV with $0.2 billion deal - Investing.com
Haleon finalizes full ownership of Chinese JV for $0.2 billion - Investing.com
Haleon Announces PDMR Share Transactions in Compliance with UK Regulations - TipRanks
Haleon PLC Executes Share Buyback Program - TipRanks
Haleon receives A3 rating upgrade from Moody's with stable outlook By Investing.com - Investing.com India
Haleon receives A3 rating upgrade from Moody's with stable outlook - Investing.com
Haleon PLC Executes Share Buyback to Enhance Shareholder Value - TipRanks
Haleon sets date for virtual 2025 Annual General Meeting By Investing.com - Investing.com South Africa
Haleon PLC Executes Share Buyback to Strengthen Market Position - TipRanks
Haleon PLC Announces Virtual 2025 Annual General Meeting - TipRanks
Haleon schedules virtual AGM for late May - Investing.com
Haleon sets date for virtual 2025 Annual General Meeting - Investing.com
Haleon updates share count and voting rights - Investing.com
Haleon plc launches £330 million share buyback By Investing.com - Investing.com South Africa
Haleon plc launches £330 million share buyback - Investing.com India
Haleon executives receive conditional share awards - Investing.com India
Haleon plc releases 2024 annual report and Form 20-F - Investing.com India
Pfizer to Exit Sensodyne-Maker Haleon With Final Stake Sale - MSN
GSK Stock Recovers, Rises Around 17% YTD: Time To Buy, Sell Or Hold? - Barchart
Pfizer Sells Remaining 7.3% Stake In Haleon For Around 3.3B - Barchart
Pfizer Sells Remaining 7.3% Stake in Haleon for Around 3.3B - Yahoo Finance
Pfizer Offloads Its Last 7% Stake In Consumer Health Haleon For Over $3 Billion - Benzinga
Haleon completes share buyback with Pfizer exit - Investing.com
Haleon completes share buyback with Pfizer exit By Investing.com - Investing.com South Africa
Haleon plc to buy back shares from Pfizer in £170 million deal By Investing.com - Investing.com South Africa
Pfizer plans to sell final stake in Sensodyne producer HaleonBloomberg - Investing.com India
Haleon plc to buy back shares from Pfizer in £170 million deal - Investing.com India
Haleon to buy back shares from Pfizer in off-market deal By Investing.com - Investing.com South Africa
Haleon to buy back shares from Pfizer in off-market deal - Investing.com India
Pfizer offers for sale entire residual shareholding in Haleon - TipRanks
Haleon reports executive share acquisitions - Investing.com India
Haleon reports executive share acquisitions By Investing.com - Investing.com UK
HSBC cuts Haleon stock rating, maintains GBP4.20 target - Investing.com
Haleon Faces Headwinds From Weak Flu Season but Reaps Benefits From New Innovations - Morningstar
Why Haleon PLC Sponsored ADR Shares Are Under Scrutiny - TipRanks
Haleon PLC Reports Strong 2024 Financial Performance - TipRanks
Haleon PLC Reports 2024 Full-Year Results with Strong Organic Growth - TipRanks
Haleon Plc Adr Azioni (HLN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):